BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29648441)

  • 1. Biocompatible Polymers Modified with d-Octaarginine as an Absorption Enhancer for Nasal Peptide Delivery.
    Miyata K; Ukawa M; Mohri K; Fujii K; Yamada M; Tanishita S; Higashitarumi S; Ishizaki S; Kumagai H; Ochiai K; Hiwatari KI; Tsubaki K; Shigeno K; Tobita E; Kobayashi H; Sakuma S
    Bioconjug Chem; 2018 May; 29(5):1748-1755. PubMed ID: 29648441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal absorption enhancement of protein drugs independent to their chemical properties in the presence of hyaluronic acid modified with tetraglycine-L-octaarginine.
    Tomono T; Yagi H; Ukawa M; Ishizaki S; Miwa T; Nonomura M; Igi R; Kumagai H; Miyata K; Tobita E; Kobayashi H; Sakuma S
    Eur J Pharm Biopharm; 2020 Sep; 154():186-194. PubMed ID: 32681963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of D-Octaarginine-Linked Polymers as an in Vitro Transfection Tool for Biomolecules.
    Mohri K; Morimoto N; Maruyama M; Nakamoto N; Hayashi E; Nagata K; Miyata K; Ochiai K; Hiwatari K; Tsubaki K; Tobita E; Ishimaru Y; Maeda S; Sakuma S
    Bioconjug Chem; 2015 Aug; 26(8):1782-90. PubMed ID: 26252905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligoarginine-linked polymers as a new class of penetration enhancers.
    Sakuma S; Suita M; Masaoka Y; Kataoka M; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Tachikawa H; Kimura R; Yamashita S
    J Control Release; 2010 Dec; 148(2):187-96. PubMed ID: 20800631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of cell-penetrating peptide-linked polymers physically mixed with poorly membrane-permeable molecules on cell membranes.
    Sakuma S; Suita M; Yamamoto T; Masaoka Y; Kataoka M; Yamashita S; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Hashizume A; Tachikawa H; Kimura R; Ishimaru Y; Kasai A; Maeda S
    Eur J Pharm Biopharm; 2012 May; 81(1):64-73. PubMed ID: 22306700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Safe Adjuvant for Mucosal Vaccination.
    Ukawa M; Tanishita S; Yagi H; Yoshida Y; Tomono T; Shigeno K; Tobita E; Uto T; Baba M; Sakuma S
    Mol Pharm; 2019 Mar; 16(3):1105-1118. PubMed ID: 30715891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-penetrating peptide-linked polymers as carriers for mucosal vaccine delivery.
    Sakuma S; Suita M; Inoue S; Marui Y; Nishida K; Masaoka Y; Kataoka M; Yamashita S; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Tachikawa H; Kimura R; Uto T; Baba M
    Mol Pharm; 2012 Oct; 9(10):2933-41. PubMed ID: 22953762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Cell-Penetrating Peptides Anchored to Polysaccharide Platforms Applied via Various Mucosal Routes as an Absorption Enhancer.
    Yagi H; Tomono T; Handa Y; Saito N; Ukawa M; Miyata K; Shigeno K; Sakuma S
    Mol Pharm; 2023 Jan; 20(1):303-313. PubMed ID: 36484773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport.
    Kamei N; Onuki Y; Takayama K; Takeda-Morishita M
    J Pharm Sci; 2013 Nov; 102(11):3998-4008. PubMed ID: 23963728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactivity of immunoglobulin A secreted on the nasal mucosa in mice nasally inoculated with inactivated H1N1 influenza A viruses in the presence of D-octaarginine-linked polymers.
    Sakuma S; Morimoto N; Nishida K; Murakami T; Egawa T; Endo R; Kataoka M; Yamashita S; Miyata K; Mohri K; Ochiai K; Hiwatari K; Koike S; Tobita E; Uto T; Baba M
    Eur J Pharm Biopharm; 2015 May; 92():56-64. PubMed ID: 25720816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the Chemical Structures of Oligoarginines Conjugated to Biocompatible Polymers as a Mucosal Adjuvant on Antibody Induction in Nasal Cavities.
    Mohri K; Miyata K; Egawa T; Tanishita S; Endo R; Yagi H; Ukawa M; Ochiai K; Hiwatari KI; Tsubaki K; Shigeno K; Tobita E; Uto T; Baba M; Sakuma S
    Chem Pharm Bull (Tokyo); 2018; 66(4):375-381. PubMed ID: 29607903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of d-Octaarginine-Linked Polymers as Promising Adjuvants for Mucosal Vaccination through Influenza Virus Challenge.
    Miyata K; Mohri K; Egawa T; Endo R; Morimoto N; Ochiai K; Hiwatari K; Tsubaki K; Tobita E; Uto T; Baba M; Sakuma S
    Bioconjug Chem; 2016 Aug; 27(8):1865-71. PubMed ID: 27463562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified translationally controlled tumor protein-derived protein transduction domain enhances nasal delivery of exendin-4 as shown with insulin.
    Bae HD; Kim M; Lee J; Lee K
    Drug Deliv; 2018 Nov; 25(1):1579-1584. PubMed ID: 30044154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction.
    Kamei N; Okada N; Ikeda T; Choi H; Fujiwara Y; Okumura H; Takeda-Morishita M
    Sci Rep; 2018 Dec; 8(1):17641. PubMed ID: 30518944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of absorption-enhancing abilities of cationic oligopeptides with short chain arginine residues through conjugation to hyaluronic acid.
    Tomono T; Yagi H; Kanemoto S; Ukawa M; Miyata K; Shigeno K; Sakuma S
    Int J Pharm; 2022 Mar; 616():121519. PubMed ID: 35093459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism on antigen delivery under mucosal vaccination using cell-penetrating peptides immobilized at multiple points on polymeric platforms.
    Ukawa M; Endo R; Yagi H; Tomono T; Miyata K; Shigeno K; Tobita E; Uto T; Baba M; Sakuma S
    Int J Pharm; 2022 Feb; 613():121376. PubMed ID: 34915143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal absorption of antibody drugs enhanced by cell-penetrating peptides anchored to a platform of polysaccharides.
    Tomono T; Yagi H; Igi R; Tabaru A; Fujimoto K; Enomoto K; Ukawa M; Miyata K; Shigeno K; Sakuma S
    Int J Pharm; 2023 Nov; 647():123499. PubMed ID: 37832700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cell-penetrating peptides on the nasal absorption of insulin.
    Khafagy el-S; Morishita M; Isowa K; Imai J; Takayama K
    J Control Release; 2009 Jan; 133(2):103-8. PubMed ID: 18930084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins.
    Khafagy el-S; Morishita M; Kamei N; Eda Y; Ikeno Y; Takayama K
    Int J Pharm; 2009 Oct; 381(1):49-55. PubMed ID: 19646515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On employing a translationally controlled tumor protein-derived protein transduction domain analog for transmucosal delivery of drugs.
    Bae HD; Lee K
    J Control Release; 2013 Sep; 170(3):358-64. PubMed ID: 23791976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.